Allient (ALNT) VP awarded 3,198 restricted shares with multi-year vesting

Rhea-AI Filing Summary

Warzala Stephen reported acquisition or exercise transactions in this Form 4 filing.

ALLIENT INC executive Stephen Warzala, VP and Group President, reported equity awards of common stock as part of his compensation. He received 1,664 time-based restricted shares that vest one-third each on April 1, 2027, 2028 and 2029. He was also granted 1,189 performance-based restricted shares that may vest over three years if performance goals for the year ending December 31, 2026 are met, and 345 performance-based restricted shares that were earned based on 2025 goals and vest one-third each on April 1, 2026, 2027 and 2028. Following these awards, his directly held common stock increased in stages to 36,028 shares, with additional indirect holdings reported through various trusts and an ESOP trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Warzala Stephen

(Last) (First) (Middle)

C/O ALLIENT INC.

495 COMMERCE DRIVE

(Street)

AMHERST NY 14228

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLIENT INC [ ALNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP and Group President

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		A		1,664(1)	A	$62.07	34,494	D
Common Stock	03/05/2026		A		1,189(2)	A	$62.07	35,683	D
Common Stock	03/05/2026		A		345(3)	A	$62.07	36,028	D
Common Stock								110,000	I	By Trust (Reporting Person as co-trustee and beneficiary)
Common Stock								2,801	I	By Trust (Reporting Person as trustee)
Common Stock								4,200	I	By ESOP Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.

2. Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. All or a portion of these restricted shares will vest over a three-year period upon the satisfaction of certain performance goals established by the Compensation Committee for the year ending December 31, 2026.

3. Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares were earned upon the satisfaction of certain performance goals established by the Compensation Committee for the year ended December 31, 2025 and vest one-third each on April 1, 2026, 2027 and 2028.

	/s/ Michael C. Donlon, Attorney-in-Fact for Stephen R. Warzala	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ALLIENT INC (ALNT) report for Stephen Warzala?

ALLIENT INC reported equity awards to Stephen Warzala, its VP and Group President. He received time-based and performance-based restricted common shares under the company’s 2017 Omnibus Incentive Plan, increasing his directly held stock while aligning compensation with future performance and service milestones.

How many ALLIENT INC (ALNT) shares were granted to Stephen Warzala?

Stephen Warzala was granted 3,198 restricted common shares in total: 1,664 time-based restricted shares, 1,189 performance-based restricted shares tied to 2026 goals, and 345 performance-based restricted shares earned on 2025 goals, all under the 2017 Omnibus Incentive Plan.

What are the vesting terms of Stephen Warzala’s time-based restricted ALNT shares?

The time-based restricted shares vest over three years. The 1,664 time-based restricted shares granted to Stephen Warzala vest in equal one-third installments on April 1, 2027, April 1, 2028, and April 1, 2029, subject to continued service and the plan’s terms.

How do Stephen Warzala’s performance-based ALNT restricted shares vest?

Performance-based shares vest based on meeting specified goals. One grant vests over three years if performance goals for the year ending December 31, 2026 are satisfied. Another grant of earned shares vests one-third on April 1, 2026, 2027 and 2028.

What is Stephen Warzala’s direct ALLIENT INC shareholding after these grants?

After the reported grants, Stephen Warzala directly holds 36,028 common shares. The filing also lists additional indirect holdings through trusts and an ESOP trust, reflecting equity interests managed in different ownership capacities.

Under which plan were Stephen Warzala’s ALNT restricted shares granted?

The restricted shares were granted under ALLIENT INC’s 2017 Omnibus Incentive Plan. This plan allows the company to issue time-based and performance-based equity awards to align executive compensation with long-term performance and shareholder interests.